Pharmacy Graduation Outcome Measures

Pharmacy Graduation Outcome Measures

LECOM On-Time Graduation Rates, Pharmacy Residency Rates, NAPLEX® and MPJE® Pass Rates

Policy regarding methods used to collect and review information on student outcomes and licensure pass rates: Data regarding student pass rates on licensure exams is collected annually from national licensing bodies and is posted to LECOM’s website. This information is collected and reviewed by the Dean of each respective program and the Provost of the institution. Once the data has been reviewed and confirmed, it is approved by the Office of Communications and Marketing for use on the website, as well as in recruitment materials.

As part of the Accreditation Council for Pharmacy Education (ACPE) policies and procedures (8.4 Policy on Program Disclosure of Specific Information), any ACPE-accredited program is required to post on its website the following information:

  • The on-time graduation rate for the most recent graduating class in the single degree pathway, i.e., the percentage of a class cohort completing the curriculum in the specified timeframe (3 calendar or 4 academic years);
  • The most recent year’s North American Pharmacy Licensure Examination (NAPLEX®)results for first-time takers as found on the NAPB Website; and
  • A measure of student achievement for the most recent graduating class as determined by the institution or pharmacy program.

The LECOM School of Pharmacy (SOP) monitors outcomes of its graduates using the on-time graduation rate, the percentage of graduates entering residency programs and the pass rate for the NAPLEX® and the Multistate Pharmacy Jurisprudence Examination (MPJE®).

On-Time Graduation and Degree Completion

The Lake Erie College of Osteopathic Medicine (LECOM) School of Pharmacy (SOP) has a three-year Doctor of Pharmacy program in Erie, Pa. a four-year Doctor of Pharmacy program in Bradenton, Fla and a four-year Doctor of Pharmacy program offered through the Distance Education Pathway. The first class of the Distance Education Pathway will graduate in 2018. On-time graduation and degree completion are reported with the exclusion of those who chose to withdraw from the program. According to the American Association of Colleges of Pharmacy website, the 5-year national average for on-time graduation is 89%.

LECOM SOP On-Time Graduation and Degree Completion Rates
  2014 2015 2016 2017
On-time Graduation 95.9% 98.6% 90.9% 95.0%
Degree Completion 98.1% 99.6% 96.5% 98.2%*

*Anticipated to graduate with the class of 2018

Residency Placement Rates

After degree completion, Doctor of Pharmacy graduates have the option of entering pharmacy practice immediately or pursuing further clinical training through pharmacy residency programs.  According to statistics from the American Society of Health-System Pharmacists, 3331 members of the 2017 graduating class matched into a pharmacy residency program.   In 2016, approximately 22% pharmacy graduates in the US entered residency programs.

LECOM SOP Graduates Entering Residency Programs
2014 2015 2016 2017
Residency Placement 11.7% 12.4% 10.4% 16.1%

Licensure Examination Pass Rates

The North American Pharmacist Licensure Examination®(NAPLEX®) and Multistate Pharmacy Jurisprudence Examination® (MPJE®) are developed by the National Association of Boards of Pharmacy (NABP) to be used by state boards of pharmacy as part of their criteria for assessing candidates’ competence to practice pharmacy. The NAPLEX® measures a candidate’s knowledge of the practice of pharmacy. The MPJE® combines federal and state-specific questions to test the pharmacy jurisprudence knowledge of prospective pharmacists.

2014 2015 2016 2017*
First Attempt LECOM Graduates 89.1% 90.0% 81.5% 86.5%
First Attempt National Average 94.9% 92.6% 85.9% 92.2%

*Preliminary results for those who took the exam on or before August 31, 2017

2014 2015 2016 2017*
First Attempt LECOM Graduates 93.9% 97.4% 88.2% 80.9%
First Attempt National Average 95.2% 94.4% 84.7% 84.9%

*Preliminary results for those who took the exam on or before August 31, 2017